Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Dexcom Inc shares valued at $526,318 were sold by Stern Sadie on May 27 ’25. At $85.11 per share, Stern Sadie sold 6,184 shares. The insider’s holdings dropped to 109,621 shares worth approximately $9.3 million following the completion of this transaction.
Also, Brown Michael Jon sold 10,000 shares, netting a total of over 842,849 in proceeds. Following the sale of shares at $84.28 each, the insider now holds 95,602 shares.
Before that, SADIE STERN had added 6,184 shares to its account. In a trade valued at $526,318, the Officer bought Dexcom Inc shares for $85.11 each.
As published in their initiating research note from Mizuho on April 10, 2025, Dexcom Inc [DXCM] has been an Outperform and the price target has been revised to $85. Analysts at Redburn Atlantic upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in early February. As of January 16, 2025, Robert W. Baird has increased its “Neutral” rating to a “an Outperform” for DXCM. Earlier on July 26, 2024, Robert W. Baird downgraded its rating. Their new recommendation was “a Neutral” for DXCM stock which previously was a “an Outperform”.
Analyzing DXCM Stock Performance
During the last five days, there has been a drop of approximately -0.04%. Over the course of the year, Dexcom Inc shares have jumped approximately 9.12%. Shares of the company reached a 52-week high of $93.25 on 02/18/25 and a 52-week low of $57.52 on 04/04/25.
Support And Resistance Levels for Dexcom Inc (DXCM)
According to the 24-hour chart, there is a support level at 83.69, which, if violated, would cause prices to drop to 82.52. In the upper region, resistance lies at 86.85. The next price resistance is at 88.84. RSI (Relative Strength Index) is 59.55 on the 14-day chart, showing neutral technical sentiment.
